21 reports

  • 4.1.1 Growing Global Spending on Medicines
  • 4.1.3 Rising Prevalence of Non Communicable Diseases

Cigarette smoking may modify inflammation associated with asthma.

  • Asthma
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • MARKET OUTLINE

The individuals who smoke cigarettes, pipes, cigars or the individuals who are exposed to second-hand smoking are at higher risk of developing the disease.

  • Asthma
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • 5.2 RISK FACTORS AND COMORBIDITIES

Currently, the cost of cigarette is too low to prevent even a young guy to start smoking.

  • Asthma
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.

These declines were attributed to changes in cigarette consumption and smoking prevalence in the Japanese population (Pham et al., 2012).

  • Asthma
  • Asia
  • Europe
  • Japan
  • World
  • 9.2.6 JAPAN

Cigarette smoking and asthma.

  • Asthma
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • RISK FACTORS AND COMORBIDITIES FOR COPD

CIGARETTE SMOKING IS THE MOST IMPORTANT RISK FACTOR FOR THE DEVELOPMENT OF COPD, AS ABOUT ##-##% OF COPD CASES ARE ATTRIBUTABLE TO SMOKING (EISNER ET AL., 2010; LAMPRECHT ET AL., 2011).

  • Asthma
  • Europe
  • World
  • Forecast
  • Social Conditions

Jeremy Hirota stated, " The use of microbial-derived products represents a novel approach to management of cigarette smoke-induced lung inflammation and may provide a unique clinical strategy for individuals suffering from chronic obstructive pulmonary disease. "

  • Asthma
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Asthma and COPD: An overview

cigarette smoke (passive smoking) Exposure to environmental pollutants such as dust, bush fires, and wood smoke Inhalation of allergens such as molds, pollen, and dust particles Exercise Diagnosis done by: Physical examination Lung tests Medical history PREVALENCE OF ASTHMA IN US AND EUROPE

  • Asthma
  • World
  • Market Size
  • DeVilbiss Healthcare LLC
  • Omron Corporation
  • REFERENCES

Cigarette smoking and asthma symptom severity among adult asthmatics.

  • Asthma
  • Chronic Disease
  • Pathology
  • Europe
  • ASP-3258 - DRUG PROFILE

EMAP II is upregulated in the lungs of cigarette smoked or exposed humans.

  • Asthma
  • Respiratory Treatment
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • Asthma
  • Clinical Trial
  • United States
  • Company Financials
  • GlobalData's company
  • Asthma
  • Clinical Trial
  • Medical Device
  • United States
  • GlobalData's company

Chronic Asthma Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: AUG 2016 LIST OF TABLES LIST OF FIGURES Chronic Asthma Global Clinical Trials Review, H##, 2016 outlines clinical trials in Chronic Asthma.

  • Asthma
  • Respiratory Treatment
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Cigarettes Montelukast Asthmatic Smoker Study (##-##) GDCT## NCT##, MK-##-##; 2005_##; EudraCT-2005-##-##; CTRI/ 2009/ ##/ ##; 2005-##-##; ##-## Respiratory Asthma, Chronic Asthma Completed Phase III Interventional montelukast sodium Merck &; Co

  • Asthma
  • Respiratory Treatment
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • ASP-3258 - DRUG PROFILE
  • ASB-14780 - DRUG PROFILE

EMAP II IS UPREGULATED IN THE LUNGS OF CIGARETTE SMOKED OR EXPOSED HUMANS.

  • Asthma
  • Respiratory Disease
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • ASP-3258 - DRUG PROFILE
  • GSK-2292767 - DRUG PROFILE

THE RESULTS DEMONSTRATED THAT INV## TREATED SMOKERS WERE MORE LIKELY TO STOP SMOKING COMPLETELY OR DRAMATICALLY REDUCE THE NUMBER OF CIGARETTES SMOKED.

  • Asthma
  • Respiratory Treatment
  • United States
  • Company
  • Product Initiative

The primary outcome measure is the change from baseline in the average number of cigarettes smoked per day.

  • Asthma
  • Autoimmune Disease
  • Research And Development
  • Therapy
  • Invion Limited
  • ASP-3258 - DRUG PROFILE
  • ASB-14780 - DRUG PROFILE

THE RESULTS DEMONSTRATED THAT INV## TREATED SMOKERS WERE MORE LIKELY TO STOP SMOKING COMPLETELY OR DRAMATICALLY REDUCE THE NUMBER OF CIGARETTES SMOKED.

  • Asthma
  • Chronic Disease
  • Pathology
  • Pharmaceutical
  • AstraZeneca PLC
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Cigarettes Montelukast Asthmatic Smoker Study (##-##) GDCT## NCT##, MK-##-##; 2005_##; EudraCT-2005-##-##; CTRI/ 2009/ ##/ ##; 2005-##-##; ##-## Respiratory Asthma, Chronic Asthma Completed Phase III Interventional montelukast sodium Merck &; Co

  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Treatment
  • World

In 2013, an estimated ##. ##% (##. ## million) U. S. adults were current cigarette smokers.

  • Asthma
  • Respiratory Monitoring
  • Asia
  • Europe
  • CareFusion Corporation

(JT Group) is a tobacco company that manufactures and sells tobacco products, primarily cigarettes.

  • Asthma
  • Research And Development
  • United States
  • Company
  • Product Initiative